Literature DB >> 19673670

Myocardial tissue engineering: the quest for the ideal myocardial substitute.

Eliana C Martinez1, Theo Kofidis.   

Abstract

There has been an intense and competitive quest to manufacture bioartificial heart muscle in the last decade. Numerous biocompatible scaffolds and scaffold-free systems, enriched with various cell types, have been used to fabricate 3D grafts for myocardial repair. In spite of the impressive achievements in the myocardial tissue-engineering field, many issues remain to be addressed before clinical application of this strategy becomes feasible. This is largely due to the uniqueness of the heart's structure and function. This review provides a survey upon the reported strategies, and indicates caveats and perspectives in the field of myocardial tissue engineering.

Mesh:

Year:  2009        PMID: 19673670     DOI: 10.1586/erc.09.81

Source DB:  PubMed          Journal:  Expert Rev Cardiovasc Ther        ISSN: 1477-9072


  9 in total

1.  Collagen scaffolds with or without the addition of RGD peptides support cardiomyogenesis after aggregation of mouse embryonic stem cells.

Authors:  Jennifer Dawson; Olivier Schussler; Ashraf Al-Madhoun; Claudine Menard; Marc Ruel; Ilona S Skerjanc
Journal:  In Vitro Cell Dev Biol Anim       Date:  2011-09-23       Impact factor: 2.416

Review 2.  Strategies for tissue engineering cardiac constructs to affect functional repair following myocardial infarction.

Authors:  Kathy Yuan Ye; Lauren Deems Black
Journal:  J Cardiovasc Transl Res       Date:  2011-08-05       Impact factor: 4.132

3.  Design and characterization of an injectable pericardial matrix gel: a potentially autologous scaffold for cardiac tissue engineering.

Authors:  Sonya B Seif-Naraghi; Michael A Salvatore; Pam J Schup-Magoffin; Diane P Hu; Karen L Christman
Journal:  Tissue Eng Part A       Date:  2010-06       Impact factor: 3.845

4.  Xenotransplantation of Bone Marrow-Derived Human Mesenchymal Stem Cell Sheets Attenuates Left Ventricular Remodeling in a Porcine Ischemic Cardiomyopathy Model.

Authors:  Masashi Kawamura; Shigeru Miyagawa; Satsuki Fukushima; Atsuhiro Saito; Koichi Toda; Takashi Daimon; Tatsuya Shimizu; Teruo Okano; Yoshiki Sawa
Journal:  Tissue Eng Part A       Date:  2015-07-14       Impact factor: 3.845

5.  Elastomeric electrospun scaffolds of poly(L-lactide-co-trimethylene carbonate) for myocardial tissue engineering.

Authors:  Shayanti Mukherjee; Chiara Gualandi; Maria Letizia Focarete; Rajeswari Ravichandran; Jayarama Reddy Venugopal; Michael Raghunath; Seeram Ramakrishna
Journal:  J Mater Sci Mater Med       Date:  2011-05-27       Impact factor: 3.896

Review 6.  Stem cells for heart failure in the aging heart.

Authors:  Victoria L T Ballard
Journal:  Heart Fail Rev       Date:  2010-09       Impact factor: 4.214

7.  Cord lining-mesenchymal stem cells graft supplemented with an omental flap induces myocardial revascularization and ameliorates cardiac dysfunction in a rat model of chronic ischemic heart failure.

Authors:  Shera Lilyanna; Eliana C Martinez; Thang D Vu; Lieng H Ling; Shu U Gan; Ai L Tan; Thang T Phan; Theo Kofidis
Journal:  Tissue Eng Part A       Date:  2013-02-28       Impact factor: 3.845

8.  Development of bioartificial myocardium using stem cells and nanobiotechnology templates.

Authors:  Juan Carlos Chachques
Journal:  Cardiol Res Pract       Date:  2010-12-29       Impact factor: 1.866

9.  Engineered heart tissue graft derived from somatic cell nuclear transferred embryonic stem cells improve myocardial performance in infarcted rat heart.

Authors:  Shuanghong Lü; Ying Li; Shaorong Gao; Sheng Liu; Haibin Wang; Wenjun He; Jin Zhou; Zhiqiang Liu; Ye Zhang; Qiuxia Lin; Cumi Duan; Xiangzhong Jerry Yang; Changyong Wang
Journal:  J Cell Mol Med       Date:  2010-12       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.